Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Reckitt Benckiser falls on baby formula recall in U.S.

Published 02/20/2023, 04:24 AM
Updated 02/20/2023, 05:43 AM
© Reuters

© Reuters

By Geoffrey Smith 

Investing.com -- Shares in Reckitt Benckiser Group (LON:RKT) fell in London on Monday after the company said it will recall more of its plant-based infant formula in the U.S., due to the risk of cross-contamination with dangerous bacteria. 

The company said it had withdrawn two batches of its ProSobee 12.9-ounce packs that were made between August and September "out of an abundance of caution", fearing that the batches may contain traces of the Cronobacter sakazakii bacteria. 

It added, however, that all of the products being recalled had been through "extensive testing and tested negative for the bacteria" before distribution. 

Cronobacter bacteria can cause life-threatening infections or meningitis. 

Reckitt described its action as a response to an "isolated situation,"  which was linked to material from a third party.

"We have taken all appropriate corrective actions, including no longer sourcing this material from the supplier," Reckitt said. 

ProSobee is a niche product in the infant formula market, being designed for babies with lactose intolerance. Reckitt owns the brand through Mead Johnson, which it bought for $16.7 billion in 2017. The acquisition, which drew criticism for being over-ambitious, was Reckitt's biggest ever and has failed to add anything to the company's share price. Reckitt stock currently trades over 15% below where it did before the deal. 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.